Delivery Order SPE2DB20D1109-SPE2DB22FP44D

Award Date 6/15/22
Potential Completion Date 6/16/22
Potential Value $34K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $3,936.07, is a delivery order to provide the ROTATEQ VACCINE 2ML to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen also holds a separate Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,265.40, is for the delivery of the ROTATEQ vaccine, a 2-milliliter treatment. This is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,147.40 Firm Fixed Price Delivery Order is for the supply of the ROTATEQ VACCINE 2ML product, with a period of performance through December 12, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.10, is a delivery order for the ROTATEQ vaccine in 2 milliliter vials. The contract has an ultimate completion date of January 28, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,693.38 for the ROTATEQ VACCINE 2ML. The award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is part of the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract is not designated as a...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $2,384.85 for the supply of the ROTATEQ vaccine, a 2ml vaccine product. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 24, 2025. The contract type is firm fixed price, and there was no set-aside designation used. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,167.82, is a Firm Fixed Price Delivery Order for the supply of the ROTATEQ vaccine, a 2ML injectable medication. The contract has an Ultimate Completion Date of January 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the ROTATEQ vaccine in 2 milliliter volumes. The firm-fixed-price Delivery Order is valued at $2,131.20 and has a completion date of February 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This federal contract award is a delivery order with a firm fixed price of $2,077.78 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ROTATEQ vaccine, a rotavirus vaccine, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,512.34 and is for the delivery of the ROTATEQ vaccine in 2 milliliter vials. The contract is a Firm Fixed Price Delivery Order with a completion date of May 1, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FP44D
    Delivery Order

This federal contract award, valued at $34,497.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs worldwide. This specific delivery order is for the ROTATEQ vaccine, a 2 ml formulation. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive capabilities in pharmaceutical distribution and its established relationships with federal agencies, particularly the Department of Defense, position the company as a critical supplier of essential medical commodities to support military healthcare needs.

Generated 2/27/25, 12:47 PM